Catecholaminergic polymorphic ventricular tachycardia 5

Any catecholaminergic polymorphic ventricular tachycardia in which the cause of the disease is a mutation in the TRDN gene.

Also known as: TRDN catecholaminergic polymorphic ventricular tachycardia, cardiac arrhythmia syndrome, with or without skeletal muscle weakness, catecholaminergic polymorphic ventricular tachycardia 5, catecholaminergic polymorphic ventricular tachycardia caused by mutation in TRDN, catecholaminergic polymorphic ventricular tachycardia type 5, CPVT5, ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness

33 clinical trials for this condition and its sub-types, 0 tagged with Catecholaminergic polymorphic ventricular tachycardia 5 itself.